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Background– Following an acute coronary syndrome, combined CT and PET with 18F-NaF can 
identify coronary atherosclerotic plaques that have ruptured or eroded. However, the processes 
behind 18F-NaF uptake in vulnerable plaques remain unclear. 
Methods and Results- Ten patients with STEMI were scanned after 18F-NaF injection, for 75 
minutes in a Siemens PET/MR scanner using delayed enhancement (LGE). They were then 
scanned in a Siemens PET/CT scanner for 10 minutes. Tissue-To-Background ratio (TBR) was 
compared between the culprit lesion in the IRA and remote non-culprit lesions in an effort to 
independently validate prior studies. Additionally, we performed a proof-of-principle study 
comparing TBR in scar tissue and remote myocardium using LGE images and PET/MR or PET/CT 
data. From the 33 coronary lesions detected on PET/CT, TBRs for culprit lesions were higher than 
for non-culprit lesions (TBR=2.11+/-0.45 versus 1.46+/-0.48; P<0.001). Interestingly, the TBR 
measured on the PET/CT was higher for infarcted myocardium than for remote myocardium 
(TBR= 0.81+/-0.10 versus 0.71+/-0.05; P=0.003). These results were confirmed using the 
PET/MR data (TBR=0.81+/-0.10 for scar, TBR=0.71+/-0.06 for healthy myocardium, P=0.03). 
Conclusions - We confirmed the potential of 18F-NaF PET/CT imaging to detect vulnerable 
coronary lesions. Moreover, we demonstrated proof-of-principle that 18F-NaF concurrently detects 
myocardial scar tissue. 
ABBREVIATIONS 
CT: Computed Tomography 
PET: Positron Emission Tomography 
STEMI: ST- elevation Myocardial Infarction 
IRA: infarct-related artery 
TBR: Tissue-To-Background ratio 
LGE: Late Gadolinium Enhancement (imaging) 







Acute myocardial infarction (AMI) is a leading cause of death and disability worldwide. AMI 
occurs when rupture or erosion of coronary atheroma leads to thrombus formation and sudden 
occlusion of a major epicardial coronary artery[1]. While coronary atheromata are commonly 
present in many middle aged and older adults, certain atheromatous plaques are more susceptible 
to rupture and erosion. Termed ‘vulnerable plaques’, these atheromata are histologically defined 
by a large lipid rich core and thin overlying fibrous cap[2, 3]. The medical imaging community 
has recognized that mere identification of atheromatous plaques[4] is insufficient as many 
atheromatous plaques are stable and not prone to rupture or erosion[5, 6]. It is therefore of great 
interest to the community to develop tools to better identify vulnerable plaques as the presence of 
these plaques may indicate an increased risk of AMI, therefore prompting escalation of medical 
treatment or targeted mechanical stabilization of vulnerable plaques by selective coronary stenting. 
Many modalities presently developed to identify vulnerable coronary plaques are invasive in 
nature, requiring the insertion of physical devices into a patient’s coronary arteries[7, 8]. Despite 
the superior spatiotemporal resolution of these invasive modalities, they carry a small but definite 
risk of causing coronary artery injury and AMI. As such, non-invasive modalities to identify 
vulnerable coronary plaques are a key unmet need in coronary artery imaging.  Recently, non-
invasive PET-CT has been used to identify high-risk plaques using 18F-NaF[9, 10]. Joshi et al.[11] 
showed that the Tissue-to-Background ratio (TBR) for culprit plaques was significantly higher 
than for non-culprit plaques (1.66 vs 1.24) on 18F-NaF PET/CT imaging of 40 patients with recent 
myocardial infarction. 
It is presently unclear if 18F-NaF has other potential uses in cardiac imaging. While it is 
acknowledged that 18F-NaF can detect culprit coronary atheromata, the mechanism behind this 
detection remains unclear. More recently, Irkle et al.[12] demonstrated preferential binding of 18F-
NaF to microcalcification. As prior studies have shown varying degrees of calcification in 
previously infarcted myocardium, we hypothesized that 18F-NaF could detect scar tissue arising 
from myocardial infarction. Moreover, 18F-NaF may possibly target apoptosis, as demonstrated in 
rat imaging[13], or macrophage infiltration and necrosis, as suggested by histological studies of 
carotid artery plaques [11], processes that are common to both atherosclerotic plaque formation 
and myocardial infarction. We therefore sought first to independently validate the use of 18F-NaF 
PET/CT imaging for the detection of high-risk coronary atheromata. Using 18F-NaF PET/MR 
imaging, we then sought to quantify the uptake of 18F-NaF in myocardial scar tissue relative to 
remote healthy myocardium to add understanding of the common processes between infarction 
and atheromata.  
MATERIALS and METHODS 
1. Study population 
For this pilot study, we enrolled 10 consecutive patients presenting with STEMI undergoing 
primary (emergency) percutaneous coronary intervention (PCI) at the National University Heart 
Centre Singapore. STEMI was determined by a typical history of ischemic chest pain or angina 
equivalent symptoms, new ST elevation at the J point in at least 2 contiguous leads of ≥2 mm (0.2 
mV) in men or ≥1.5 mm (0.15 mV) in women in leads V2–V3 and/or of ≥1 mm (0.1 mV) in other 
contiguous chest leads or the limb leads, accompanied by a typical rise and/or fall of cardiac 
troponin[14]. All patients had an acute occlusion of an infarct-related artery (IRA) on coronary 






onset. After PCI, consented patients were screened for eligibility and were then scanned at a 
median of 13.5 days (range 9-24) after the acute event on the PET/MR followed immediately by 
PET/CT. 
We excluded patients with MR contraindications such as metallic implants, pacemakers or 
claustrophobia. Additionally, we excluded patients with severe renal and liver impairment, 
significant valvular heart disease, and a history of malignancy.  
The study was approved by the National Healthcare Group Domain Specific Review Board (DSRB 
reference number 2013/00248) and written informed consent was obtained from all patients. 
 
2. PET/MR image acquisition and reconstruction 
All subjects were first scanned on a Biograph mMR PET-MR scanner (Siemens Healthineers, 
Erlangen, Germany) for 75 minutes. MRI and PET scans were performed simultaneously on a 
single bed centered over the heart. The PET-MRI scan was started immediately after intravenous 
injection of 2.95 +/- 0.21 mCi 18F-NaF. PET data was reconstructed from the last 15 minutes (60-
75 min after injection) using an iterative reconstruction (Siemens OP-OSEM algorithm, 3 
iterations, 21 subsets, matrix size 344x344 with Point Spread Function[15] correction) without 
ECG or respiratory gating to decrease the level of noise.  The UMAP was created from a Dixon 
MRI sequence acquired at the beginning of the PET recording. The reconstructed images were 
smoothed with a 2mm FWHM Gaussian filter, matching the voxel dimension of 2 x 2 x 2 mm. 
18F-NaF uptake in the scar and remote myocardium was quantified by the standardized uptake 
value (SUV). 
 
3. Cardiovascular Magnetic Resonance (CMR) Protocol and Measurements 
Image Acquisition:  
In addition to the localizer, the MRI cardiac imaging protocol included a breath-hold CINE steady 
state free precession (SSFP) short axis view covering both the right ventricle (RV) and the left 
ventricle (LV). Delayed enhancement (LGE) short axis images were acquired 10 minutes after a 
0.2mmol/kg GADOVIST injection. Sequential parameters of the LGE acquisition were the 
following: TR=4.1ms, Average R-R interval=990ms, TE=1.56ms, Slice thickness=8mm, 
Gap=20%, FOV=276 x 340 mm, Matrix= 133 x 256, Flip angle=20, Inversion time=subject-
specific calculated using TI scout, Image resolution=1.33 x 1.33 x 10 mm.  
Image Analysis:  
All CMR sequences were analyzed jointly by 2 trained image analysts using the 510k FDA cleared 
software Segment version 1.9 R3556[16]. Left Ventricular (LV) segmentation of the endocardium 
and epicardium was performed automatically on all timeframes of the short-axis CINE stack. 
Manual adjustment of the contours was performed if necessary, following the SCMR 
guidelines[17]. In addition, LGE images were analyzed by delineating the LV endocardium and 
epicardium manually and extracting the scar tissue automatically using Otsu’s threshold[18].  
 
4. PET/CT image acquisition and reconstruction 
Of the 10 subjects who underwent PET/MR scanning, two subjects declined subsequent PET/CT 






PET/CT scanner (Siemens Healthineers, Erlangen, Germany). A non-enhanced coronary artery 
calcium score CT scan (120 kV, 120 quality reference mAs, CareDose, 300 ms exposure time, 
128x0.6 mm collimation, non-triggered acquisition) and a low dose CT attenuation correction scan 
were first performed using the 128-row CT scanner in the PET/CT system. The calcium scan was 
reconstructed at a slice thickness of 3 mm using an iterative reconstruction (Siemens SAFIRE) to 
allow high resolution imaging of the coronary arteries. 
The CT scans were immediately followed by a 10 min PET scan (one bed position centered over 
the heart). The scan time was limited to 10 minutes to ease the protocol for the patients who 
previously underwent 75 minutes of PET/MRI scanning. The PET scan was started at least 90 min 
post 18F-NaF injection (108 +/- 21 min) and was reconstructed using an iterative reconstruction 
(Siemens OP-OSEM algorithm, 3 iterations, 21 subsets, 2 mm pixel size, 2mm FWHM Gaussian 
filter), with attenuation and scatter corrections included as well as Time of Flight[19] and Point 
Spread Function[15] correction. Although the PET scan was acquired using respiratory and cardiac 
gating, the gated information was not used in the reconstruction as it resulted in images with 
suboptimal count statistics. 
 
5. Tissue-To-Background ratios calculation 
Coronary atheromata TBR from PET/CT: 
Calcium regions within the arteries were delineated manually on the CT image, having higher 
intensities than surrounding blood as shown Figure 1. Additionally, each vessel containing at least 
one calcium region was partly segmented manually from axial slices of the 3D CT image. Hybrid 
PET-CT acquisition ensures the direct transposition of these Regions of Interest (ROIs) on the 
PET image, therefore enabling the automatic measurement of SUV within each region. This direct 
transposition of the ROIs does not guarantee an optimal quantification of SUV due to the rapid 
motion and small size of the atheromata as it has been demonstrated before[20]. Since a consensus 
on solving these misregistration problems has not been validated yet, the authors decided to use a 
simple approach and measure the TBR of each calcium ROI as already validated by Josh et al.[11]. 
It is defined as the ratio between the calcium region maximum SUV over the corresponding vessel 
(excluding the calcium ROIs) mean SUV: 
             (   ) =       (   )       (      ) 
Myocardial infarct TBR from PET/MR: 
In order to correct possible misalignment between the LGE images acquired half way through the 
CMR protocol on 10-15 breath-holds, and the PET/MR image acquired continuously over 15 
minutes towards the end of the CMR protocol, a first automatic registration was performed. As 
described before, LGE short-axis images were first analyzed in order to extract the scar regions 
and the healthy myocardium regions. The images and resulting masks were then resampled to an 
isotropic resolution (1.33 x 1.33 x 1.33 mm) for a better fit with the PET image. As described Fig.2 
(left), the Dixon (in-phase) image acquired along the PET is first resampled to the same short-axis 
acquisition plane as the LGE image to ease the registration between the two images. An in-house 
algorithm (developed using ITK libraries) using well validated mutual information metric[21] to 
perform the rigid 3D registration was used. Despite the different image intensities in both images 
(the myocardium is not visible on Dixon), the registration was successful as Fig.2 (left). 






ROIs were reported directly on the Dixon (for verification) and the PET image for SUV 
quantification. The TBR in the myocardium was defined differently from the TBR in the 
atheromata, as the mean SUV within the ROI (scar or remote myocardium) divided by the mean 
SUV within the left ventricle blood pool away from the walls:  
             (   ) =        (   )       (             ) 
The mean SUV of the ROI was considered instead of the max SUV to account for the large scar 
and remote myocardium regions compared to the atheromata ROIs. Although the blood pool may 
show local turbulence, the averaged value of blood pool SUV acquired over 15 minutes of PET 
acquisition was chosen to normalize the infarct (and remote myocardium) uptake since it is 
assumed to be consistent across patients who underwent an identical protocol. 
 
Myocardial infarct TBR from PET/CT: 
As the PET data acquired on PET/CT were of higher quality than the PET-MRI data, myocardial 
infarct TBRs were also measured on the PET/CT to confirm the results. As described Fig.2 (right), 
the LGE MRI images had first to be aligned to the PET/CT images. First the CT images were 
resampled on the scanner software Siemens SAFIRE in order to obtain short-axis views (2mm 
thickness), and 2 chamber and 4 chamber views corresponding to the MRI LGE image orientation.  
Then, MedINRIA 1.9[22] image fusion software was used for a manual landmark based rigid 
registration to align the isoresampled LGE image and masks (obtained from the LGE to PET/MR 
registration step) to the resampled CT image chosen as the reference image. The junctions between 
outflow and inflow vessels were used as landmarks for the co-registration as well as the apex tip. 
Similarly to the PET/MR registration, the resulting transformation was then applied to deform the 
myocardium and scar ROIs. Fig. 2 (right) shows an example of the final alignment of the 
segmentations on CT (for verification) and PET images, with good agreement despite the lack of 
muscle landmark on the non-contrast CT. After registration, registered scar ROIs and remote 
healthy myocardium were reported directly on the PET image and SUV and TBR values extracted 
identically to the PET/MR method.  
 
6. Angiography examination 
Patients underwent emergent coronary angiography and primary percutaneous coronary 
intervention for STEMI via transradial or transfemoral access. Coronary angiograms were 
acquired on a Siemens biplane system Artis system (Siemens, Munich, Germany) using 
standardized tomographic views of right anterior oblique caudal, anterior posterior cranial, left 
anterior oblique cranial and left anterior oblique caudal for the left coronary system, and left 
anterior oblique cranial and right anterior oblique for the right coronary system. The volume of 
contrast (Omnipaque) used for each coronary angiogram was typically between 25-50 ml. All 
patients underwent manual thrombectomy, balloon angioplasty and coronary stent implantation as 
directed by the primary operator.  
Culprit plaques were spatially defined by the presence of an occlusive or subocclusive lesion 
within the IRA corresponding to electrocardiographic and echocardiographic localization. Culprit 
lesions on coronary angiography were then mapped to corresponding calcium regions on the CT 







7. Statistical analysis 
Coronary atheromata: 
The TBR of identified culprit and non-culprit lesions were compared statistically using a 2-tailed 
Student’s t-test and the mean and standard deviation (SD) for culprit versus non-culprit plaques 
recorded. The effect size (d) using Cohen’s definition (difference of the group means divided by 
the average standard deviation) was also calculated in order to judge the magnitude of the 
difference (d ≥ 0.8 is considered a large difference[23]). From the mean and standard deviation of 
the culprit and non-culprit plaque TBR, 95% confidence intervals (CI) were computed (mean+/-
1.96SD). Using these non-overlapping intervals, a cutoff-value was defined as the mean between 
the lower bound of the 95% CI of culprit plaques and the higher bound of the 95% CI of non-
culprit plaques. Sensitivity and specificity values to classify high and low-risk plaques with this 
cutoff value were then calculated.  
 
Myocardial infarct: 
TBR between scar and remote myocardium were compared statistically using a 2-tailed Student’s 
t-test and Cohen’s effect size to account for the small sample size. Statistical software package in 
Matlab R2013b was used for all analyses and a 2-sided α of 5% was considered statistically 
significant. A Pearson’s correlation was also established between the PET/MR and PET/CT SUVs. 
RESULTS 
1. Baseline characteristics  
The cohort comprised of 9 men and 1 woman with a mean age of 48 + 7 years. All received a 
loading dose of aspirin and ADP-receptor inhibitor before the coronary intervention and had a 
median door-to-balloon time of 42 minutes (interquartile range 24). Median peak Troponin I was 
69.5ng/ml (interquartile range 45.6), indicating significant myocardial damage. Two subjects 
declined to undergo PET/CT after the first PET/MRI scan. Baseline and CMR characteristics are 
shown in Table 1. 
 
2. Visual analysis 
Coronary atheromata: 
Atheromatous plaques were segmented on the CT calcium scoring image as regions of high 
intensity (white) within the coronaries (see Fig.1c). Hybrid PET/CT imaging allowed automatic 
co-registration of the coronary anatomy and the PET image. This can however be imperfect due 
to patient, respiratory and cardiac motions. Visual distinction of vulnerable plaques was 
challenging due to the small size of the plaques, the limited resolution of the PET image, as well 
as respiratory and cardiac motion, leading to high partial volume effect (see Fig.1d). In the example 
shown in Figure 1, the culprit (high risk) plaque as assessed by angiography corresponds to ROI1 
while ROI2 was diagnosed as a low risk plaque. On the PET image, a visual difference in uptake 
between the two ROIs is noticeable, however, the maximal SUV of the culprit plaque is of the 
same order of magnitude as the noise in the surrounding blood. This non-specific uptake renders 
the detection of vulnerable plaques impossible if SUVs of plaques are compared without 








Report of the myocardium and scar ROIs after registration of the LGE image and the PET/CT was 
visually successful (as assessed by two independent observers) on all cases allowing confidence 
in the measurements. Similarly, the automatic registration of LGE and Dixon (to align with 
PET/MR) was necessary for 2 of the 10 cases and allowed to correct for patient motion. The other 
8 patients showed more stillness during the scan leading to already aligned images (as assessed by 
two independent observers) for which the automatic registration showed no improvement.  
Visual distinction of scar tissue on the PET images (both PET/MR and PET/CT) was as 
challenging as for the atheromata. An example is shown Fig.2 (left for PET/MR and right for 
PET/CT on the same patient) in which most parts of the scar have higher uptake than the average 
myocardium. However, partial volume effect, breathing and cardiac beating reduce the uptake to 
a low value. One can also notice that the uptake in the blood pool is globally higher than in the 
myocardium. Once again the uptake is not specific to the scar and similar uptake is observed in 
the turbulent blood pool or surrounding tissue. For a better comparison of regional muscle uptake, 
PET images were masked to the full myocardium and overlaid on LGE images as shown Fig.3. 
Clear distinction can be made between healthy and infarct uptake. However, as one can notice, the 
uptake is not homogeneous within the scar region. 
 
3. Parametric comparison 
Coronary atheromata: 
From the 33 detected lesions on CT, 8 were identified as being culprit on the standard coronary 
angiogram, 1 for each patient undergoing PET/CT. The TBR of the culprit lesions was found 
significantly higher than the TBR for non-culprit lesions (Fig.4 left) with an average value of 2.11 
for culprit (±0.42) and 1.36 (±0.30) for non-culprit (p-value < 0.001, d=1.77). Considering only 
non-overlapping confidence intervals, a threshold for the classification of high-risk and low-risk 
lesions was defined at 1.70. This led to a specificity of 72%, a sensitivity of 87.5% and an accuracy 
of 75.7% for detecting culprit coronary atheromata in these 8 patients.  
 
Myocardial scar: 
Nine of the 10 patients had clear visible zones of scar tissue defined on the LGE image. In the 
patient without clear LGE, the IRA was the right posterior descending artery (RPDA), which is 
the likely reason for the absence of definite scar. Scar percentages are reported in Table 3 along 
with the TBR and SUV for scar relative to remote healthy myocardium for each patient and each 
image modality. The TBR was found to be significantly higher in scar tissue than in the remote 
healthy myocardium with an average value of 0.87 (± 0.10) for scar and 0.72 (±0.05) for remote 
myocardium (p-value=0.003, d=1.86) on the PET/CT for the 8 patients (Fig.4 right). Similarly, 
despite lower image quality of the PET/MR, the TBR was also found significantly higher in scar 
tissue (TBR=0.81±0.10) than in remote myocardium (TBR=0.72±0.06), (p-value=0.03, d=1.55) 
for the 10 patients. Additionally, including only the 8 patients that underwent both PET/CT and 
PET/MR, SUV measured with PET/CT and PET/MR showed significant Pearson’s correlations of 
0.75 for scar and 0.71 for remote myocardium despite the small number of patients. From the 
PET/MR data, there was no significant correlation between the size of the scar tissue and the 
uptake (p-value=0.91, R=-0.04 between scar size and TBR scar, p-value=0.33, R=-0.36 between 






also no correlation between the scar size or the uptake with respect to the PCI-to-Scan time (p-
value=0.28, R=-0.40 between TBR scar and PCI-to-Scan time; p-value=0.33, R=-0.36 between 
SUV scar and PCI-to-Scan time; p-value=0.34, R=-0.35 between scar size and PCI-to-Scan time). 
DISCUSSION 
Our study results first confirm previous findings of successful 18F-NaF differentiation of culprit 
coronary atheromata in the IRA of patients with recent STEMI, despite noisy PET images and a 
non-optimal protocol that do not allow direct visual assessment. As shown, and contrary to Joshi 
et al.[11], a distinct identification of culprit plaques on the PET images was hardly noticed in our 
study despite the highly significant TBR differences. This difference may be due to respiratory 
and cardiac motion, small size of the lesions leading to high partial volume effect or insufficient 
injected activity. A longer scan time would have allowed ECG and respiratory gating, probably 
leading to more accurate results, less partial volume effect and improved image quality. 
Additionally, new reconstruction algorithms can be thought of to reduce the noise level (for 
instance, the work by Rubeaux et al.[20]). Nevertheless, the amount of noise from all these factors 
affects the TBR of all plaques, making the culprit vs non-culprit comparison relevant. In addition, 
this pilot study included a small cohort of patients as an initial proof of concept of concomitant 
coronary and myocardial 18F-NaF PET imaging. Despite the limitations of our protocol, the 
limited study size and the unspecific uptake, the difference in TBR were highly significant proving 
once more the potential of such an approach to differentiate between atheromata. As for all other 
similar studies, patients were scanned after PCI which is likely to have affected the plaque prior to 
scanning. Joshi et al.’ histological validation[11] indicates nonetheless that this is not a major 
limitation. The accuracy of only 76%, however, tends to confirm previous skepticism on the 
clinical value of the method since more than one plaque might have ruptured unnoticed[8]. It is 
therefore clear that more research is still required before 18F-NaF PET imaging can be used as a 
diagnostic tool and more validation needed in order to establish a PET threshold to define a 
vulnerable plaque. For now, as described in the “myth of the vulnerable plaque” by Arbab-Zadeh 
and Fuster[24], a more sensible approach will be to treat systemic risk rather than focus on specific 
high risk plaques. 
The main contribution of this study was to identify, for the first time in humans, simultaneous 18F-
NaF uptake in myocardial scar in the territory supplied by the IRA using both PET/CT after 
registration with LGE and PET/MR. Co-registration with CMR enabled structural myocardial 
information otherwise unavailable from the CT images to be incorporated into the PET/CT 
analysis and directly compared with the PET/MR analysis. Despite spillage from the left 
ventricular blood pool that could affect the SUV for both myocardial scar (mainly transmural in 
our study) and remote myocardium, partial volume effect due to respiratory and cardiac motion, 
and potential misregistration between non-contrast CT and MRI and between PET/MR and LGE, 
we demonstrated twice that 18F-NaF is taken up by both culprit coronary atheromata and 
myocardial scar tissue. PET/MRI acquisition does not include Time of Flight, and the 
reconstruction is based on a UMAP of lower accuracy than what is obtained from a CT scan. 
Despite these limitations, the results correlated with the PET/CT results which strengthens our 
hypothesis that 18F-NaF targets myocardial scar significantly. Additionally, the non-homogenous 
uptake of 18F-NaF in the myocardial infarct seems to indicate various processes occurring in post-
MI regions that LGE MRI does not report on. Further studies are warranted to characterize these 






as our data suggest that 18F-NaF imaging reports on biological processes beyond that elucidated 
by LGE MRI.  
Previous studies intended to explain why 18F-NaF binds to ruptured or vulnerable plaque offer the 
following hypothesis: atherosclerotic vascular calcification is a cellular response to necrotic and 
chronic inflammatory stimulus[11], therefore directly linked to inflammation. Additionally, 
fluoride ions are incorporated in the process of microcalcification[5, 6]. Recently Irkle et al.[12] 
differentiated stable macrocalcification from high risk microcalcification therefore explaining the 
preferred binding of 18F-NaF to culprit plaques. Moreover, Irkle et al.[12] proved that this specific 
uptake in the culprit plaques did not correlate with any markers of inflammation which therefore 
excludes the hypothesis that 18F-NaF targets inflammation resulting from stent injury in the artery 
or any other inflammation processes. 
Studies have identified calcification of infarcted myocardium on CT images and in postmortem 
examinations[25]. In canine models of AMI, permanent coronary ligation did not increase the 
uptake of radio-labelled 45Ca-CaCl but ischemia followed by reperfusion led to an 18-fold 
increase in calcium uptake in the injured myocardium[26, 27]. Calcium uptake is postulated to be 
an active process associated with mitochondrial accumulation of calcium into dense 
intramitochondrial granules of calcium phosphate. Mitophagy of cardiomyocytes, is often 
triggered by massive calcium influx into cardiomyocyte mitochondria exposed to ischemia-
reperfusion injury. The uptake of mitochondrial is a feature of irreversible cellular injury and may 
be related to defects in mitochondrial membrane permeability. Moreover, increased uptake 
calcium could also be due to retention of calcific deposits in the extracellular space present due to 
myocyte death or from the myocyte necrosis process itself[28]. Our study did not include 
histological findings to determine with certainty the common processes between myocardial 
infarct and culprit atheromata uptake but we hypothesize that many of the cell death mechanisms 
in atherosclerotic plaque disruption are common to myocardium exposed to ischemia-reperfusion 
injury.  
New Knowledge Gained 
The use of 18F-NaF PET/CT imaging to detect high-risk coronary lesions in patients with STEMI 
is confirmed in a small Asian population. The comparison of 18F-NaF uptake in myocardial scar 
tissue with remote healthy myocardium shows, for the first time in humans, that 18F-NaF also binds 
to myocardial scar tissue. 
 
These data serve as proof-of-principle that first, pathobiological processes involving 
microcalcification may be common to both atherosclerotic plaque disruption and myocardial 
infarction and second, 18F-NaF PET/CT could be potentially applied to simultaneous coronary and 
myocardial imaging applications to quantify both vulnerable plaque burden and myocardial scar 
tissue.  
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Table 1. Baseline and CMR characteristics 
 PET/MR  + PET/CT 
Population Size, n 10 8 
Age, yrs (SD) 48.2 (7.4) 46.9 (7.7) 
Male, n (%) 9 (100) 8 (100) 
Hypertension, n (%) 2 (20) 1 (12.5) 
Dyslipidemia, n (%) 1 (10) 1 (12.5) 
Current Smoker, n (%) 3 (30) 3 (37.5) 
DAPT at discharge, n (%) 10 (100) 8 (100) 
LV ejection fraction, % 
(SD) 
62.3 (6.7) 59.9 (4.8) 
LV mass, g (SD) 139.6 (22.5) 140.6 (25.4) 
LV end-diastolic volume, ml 
(SD) 
121.9 (10.9) 122.8 (11.3) 
LV end-systolic volume, ml 
(SD) 
46.2 (10.5) 49.5 (8.8) 
LV stroke volume, ml (SD) 75.8 (8.5) 73.3 (6.5) 
Presence of scar tissue, n 
(%) 
9 (90.0) 7 (87.5) 
Peak Troponin I level, ng/ml 
(SD) 
48.5 (30.4) 55.9 (29.0) 
PCI to Scan time (days, SD) 15.1 (4.5) 15.5 (5) 










Table 2. Per patient comparison of the culprit and non-culprit Tissue-to-Background ratio 
Patients 1 2 3 4 5 6 7 8 Mean 
(SD) 
Position of 
rupture RPDA LAD LAD LAD LAD LAD LAD RCA  
Num. of 
ROIs 8 4 3 3 2 4 3 6  
TBR culprit 2.45 2.72 2.27 2.40 1.33 1.88 2.14 1.70 2.11** (0.42) 
TBR non-
culprit 1.57 1.61 1.14 1.08 0.80 1.37 1.73 1.62 
1.36** 
(0.30) 
TBR=Tissue-to-Background Ratio, RPDA= right posterior descending artery, LAD= left anterior 
descending artery, RCA= right coronary artery, ROI= region of interest, ** p-value < 0.01 
 
 
Table 3. Per patient comparison of the scar and myocardium Tissue-to-Background ratio 
Patients 1 2 3 4 5 6 7 8 9 10 Mean (SD) 
Scar % 4.7 NA 28.1 20.6 16.6 13.1 13.9 41.4 16.6 11.2 18.4 (10) 
PCI to Scan 
































PET/MR 0.76 0.73 0.76 0.76 0.78 0.72 0.64 0.73 0.69 0.58 
0.72* 
(0.06) 









Fig. 1 Example of 18F-NaF PET-CT detection of a ruptured plaque. a) Definition of the coronary 
arteries, by “Robin Smithuis and Tineke Wilems, the Radiology Assistant”.  b) Angiogram 
examination showing plaque rupture and acute occlusion at proximal LAD. (RI represents a large 
Ramus Intermedius) c) CT calcium scoring images in the axial view where the LAD and 2 ROIs 
have been segmented. d) Corresponding PET image with the reported segmentations, images were 









Fig. 2 (Left: PET/MR) Description of the LGE to PET/MR registration that leads to the 
measurement of scar Vs heathy myocardium TBR. (Right: PET/CT) For the same patient, 
description of the LGE to PET/CT registration. With both modalities, higher uptake is noticeable 







Fig. 3 Example of LGE image showing extensive infarct tissue (arrows) in short-axis (a) and 2-
chamber (c) views. 18F-NaF PET uptake was overlaid on the myocardium muscle on images (b) 





Fig. 4 (Left) Boxplot representation of the 2 groups of lesions showing a significant difference in 
TBR between the culprit and the non-culprit lesions. (Right) Boxplot representation of the 
myocardium uptake using both the PET/CT and the PET/MR modalities 
